Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

ICON Ups China Presence and Posits Double-Standard in China Trials

publication date: Mar 29, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
ICON plc,, the global clinical-stage CRO based in Ireland, is adding to its China facilities, opening a new office in Shanghai and increasing the space of its Beijing operation. Separately, ICON said a double standard exists in China clinical trials, with different levels of quality separating trials for multinationals from those conducted for local products. More details....

Stock Symbol: (NSDQ: ICLR)     Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...